- Home
- / Syntekabio
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Syntekabio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩4.5 K
2024-10-29
Market Capitalization
₩67.4 B
2024-10-29
Revenue
₩3.4 B
FY, 2025
CreditSafe Score
?
Score changed on Jul 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 609.7M | 316.7M | 244.0M | 123.4M | 120.9M | 3.4B |
| Cost of goods sold | (253.4M) | (291.8M) | (233.9M) | |||
| Gross profit | 612.5M | 431.3M | 465.8M | 394.6M | 417.4M | 3.7B |
| Gross profit margin, % | 100.5% | 136.2% | 190.9% | 319.8% | 345.3% | 107.0% |
| Operating expense total | 6.6B | 8.1B | 10.6B | 10.9B | 12.4B | 12.4B |
| Depreciation and amortization | 1.1B | 1.2B | 1.5B | 1.8B | 2.3B | 2.1B |
| EBITDA | (6.0B) | (7.6B) | (10.1B) | (10.5B) | (12.0B) | (8.7B) |
| EBITDA margin, % | -990.2% | -2406.0% | -4138.4% | -8505.7% | -9935.2% | -254.7% |
| EBIT | (7.1B) | (8.8B) | (11.6B) | (12.9B) | (14.4B) | (15.3B) |
| EBIT margin, % | -1163.6% | -2771.6% | -4751.0% | -10480.5% | -11939.3% | -444.9% |
| Interest income | 690.9M | 374.4M | 971.8M | 1.2B | 349.1M | 26.7M |
| Interest expense | 84.4M | 254.2M | 1.3B | 375.7M | 2.0B | 2.8B |
| Pre tax profit | (6.5B) | (14.8B) | (4.5B) | (11.4B) | (7.2B) | (17.4B) |
| Net Income | (6.5B) | (14.8B) | (4.5B) | (11.4B) | (7.2B) | (17.4B) |